Lobbying Spend
—
Filings
35
Firms Hired
2
Active Period
1999–2013
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Preserve Access to Affordable Generics Act
2013 · first_quarter · Firm: FIERCE, ISAKOWITZ & BLALOCK
S. 214- Preserve Access to Affordable Generics Act, drug patent settlements
Client expense: — · Firm income: $80,000
Matched citations: S. 214
Food and Drug Administration Reform Act of 2012
2012 · second_quarter · Firm: FIERCE, ISAKOWITZ & BLALOCK
Drug Shortages, Generic Drug User Fees, Classification of Hydrocodone Products, S. 3187- Food and Drug Administration Safety and Innovation Act, H.R. 5651-Food and Drug Administration Reform Act of 2012
Client expense: — · Firm income: $80,000
Matched citations: H.R. 5651
Veterans Health Equity Act of 2009
2010 · fourth_quarter · Firm: FIERCE, ISAKOWITZ & BLALOCK
S. 239: Preserve Access to Affordable Generics Act
Client expense: — · Firm income: $15,000
Matched citations: S. 239
Source: Senate LDA